Andrew R. Mariniello

Andrew has helped clients navigate complex deals ranging in value from millions to billions of dollars across a wide variety of industries—including technology, life sciences, healthcare, real estate, manufacturing, and financial services. He has counseled public and private companies on corporate governance and transactional matters.  In addition, Andrew has experience in the field of royalty monetizations, advising both investors and royalty holders in the structure and negotiation of a variety of royalty monetization transactions.

Before joining Morgan Lewis, Andrew was a senior corporate associate in the New York office of a major international law firm. He received his J.D. from the University of Pennsylvania Law School, before which he worked as a financial analyst in the real estate investments department of an international insurance company in New York.

Private Equity

• Community Brands, a portfolio company of Insight Venture Partners, GSV Acquisitions LLC and Providence Equity Partners, in its acquisition of Parent Apps Limited (UK), an online platform and mobile app for schools and nurseries to communicate with parents
• Providence Strategic Growth Partners and its portfolio companies in transactions involving SignUpGenius, Inc. and Formstack.
• Greater Sum Ventures and its portfolio companies in transactions involving Vacation Brands, LLC, Inhabit IQ, Tribute Technologies, and Care Brands. 
• Community Brands (a portfolio company of Insight Venture Partners) in numerous transactions including acquisitions of TripBuilder Media, Inc., Givesmart UK Limited, Expo Logic, NimbleUser, 501 Auctions, LLC, Gesture, Configio, and inResonance.
• Ministry Brands, LLC (a portfolio company of Insight Venture Partners) in numerous transactions including acquisitions of YSL, LLC (d/b/a Churchstreaming), Sharefaith, Inc., Kindrid, LLC,  Faith Direct, LLC, and DonorDirect.com, Inc.
• Tait (formerly Tait Towers) (a portfolio company of Providence Equity Partners), in its acquisitions of Kinesys Projects Limited, a leader in motion control technology, and Brilliant Topco Limited, a premier provider of staging and design capabilities for live events.
• Arcoro Inc. (a portfolio company of Providence Strategic Growth Partners) in its acquisition of InfinityHR, an innovative leader in human capital management software. 

Public Company M&A

• Liberty Property Trust (NYSE: LPT), a real estate investment trust, in its $12.6 billion sale to Prologis, Inc. (NYSE: PLD).
• Svenska Cellulosa Aktiebolaget in its $513 million acquisition of Wausau Paper Corp. (NYSE: WPP), one of the largest away-from-home tissue companies in North America.  
• Health Net, Inc. (NYSE: HNT), a managed care organization, in its $6.8 billion sale to Centene Corporation (NYSE: CNC).
• Contango Oil and Gas (NYSE: MCF) in the $390 million acquisition of Crimson Exploration Oil and Gas (NASDAQ: CXPO), an oil and natural gas exploration and development company.
• Verso Paper Corp. (NYSE: VRS) in its $1.4 billion acquisition of Newpage Holding Corporation from Centerbridge Partners and in the sale of NewPage Corporation's Biron paper and Rumford pulp and paper mill to Catalyst Corporation.

Private Company M&A

• Rockfarm Supply Chain Solutions and Global Distribution and Logistics, a tech-enabled transportation logistics company with a focus on flexible, customer-driven service, in its sale to Redwood Logistics
• Iron Mountain Inc. (NYSE: IRM), a provider innovative storage and information management services, in the $220 million sale of its Intellectual Property Management business to NCC Group
• Lumaverse Technologies, a provider of constituent management and engagement software for education, nonprofits and businesses, in a recapitalization led by L Squared Capital Partners
• Ministry Brands in its acquisition of the businesses of WeShare, a platform for online giving for parishes throughout the US, and WeGather, a cloud-based software solution that helps parishes manage its business and connects staff with members and visitors, from Liturgical Publications Inc.
• Synovos, Inc., an integrated supply chain management services provider, in its $145 million sale to Electrocomponents plc (LON: EMC)
• BP (NYSE: BP) in its joint venture with ArcLight Capital Partners and the joint venture’s acquisition of Thornton’s Inc., a Louisville, KY–based company that operates a chain of 191 convenience stores throughout the Midwest.
• Iron Mountain Inc. (NYSE: IRM) in its $1.3 billion acquisition of IO Data Centers LLC, a leading co-location data center service provider.
• Harron Communications, L.P. in the sale of MetroCast Systems to Block Communications and in the sale of all of its cable systems operating under the MetroCast brand name to Atlantic Broadband, a subsidiary of Cogeco Cable Inc.
• The Navigator Company, S.A., a Portuguese pulp and paper company, in its sale of a wood pellet production plant in Greenwood, SC to Enviva Holdings LP.
• Transcontinental (TSX: TCL.A, TCL.B) in its acquisitions of Robbie Manufacturing, Ultra Flex Packaging Corp., Coveris Americas, and Capri Packaging.
• Harte Hanks (NYSE: HHS) in the sale of its Trillium Software business to Clearlake Capital Group, L.P. backed by Syncsort Incorporated; the sale of its B2B research businesses, Aberdeen Group and Harte Hanks Market Intelligence, to subsidiaries of Halyard Capital; and its acquisition of Silicon Valley–based digital marketing agency 3Q Digital, Inc.
• Liberty Property Trust (NYSE: LPT), a real estate investment trust, in its $1.5 billion acquisition of Cabot Industrial Fund III. 
• Innopharma, Inc., a privately held pharmaceutical development company, in its $225 million sale to Pfizer Inc. (NYSE: PFE) 

Royalty Monetizations

• Ligand Pharmaceuticals in its royalty financing agreement with Castle Creek Biosciences, Inc. to support the Phase 3 clinical study of D-Fi, Castle Creek’s lead candidate, in patients with dystrophic epidermolysis bullosa
• Healthcare Royalty Partners in a private placement of $100 million in senior convertible notes and in numerous royalty monetization transactions, including acquisitions of royalty and revenue interests from inventors, universities, and numerous companies including Infinity Pharmaceuticals Inc., Acorda Therapeutics Inc., and Albireo Pharma Inc.
• Ligand Pharmaceuticals in its purchase of third-party and synthetic royalty interests from Agenus Inc. to support Agenus’s ongoing botensilimab and balstilimab clinical development program

Results may vary depending on your particular facts and legal circumstances.